FDA officials say the persistence of patient groups and CDRH director Jeffrey Shuren's support pushed the agency to incorporate patient views into their review process.
Kathryn O'Callaghan, acting associate director for Science and Strategic Partnerships at CDRH, says the agency has been working to consider patient views as part of device reviews such as by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?